Startups
Cell Care Therapeutics is developing a new class of biologics that are derived from the secreted proteins and exosomes of mesenchymal stromal cells (MSCs). The company’s novel secretome platform harnesses the signaling molecules of MSCs to promote the health of blood vessels and their surrounding tissue. The company is developing its first product for the treatment of diabetic macular edema, the leading cause of vision loss in working age adults.
Overview
Location
United States, California, Monrovia
Employees
1-10
Phone
562 528
Total raised
$4.3M
Founded date
2014
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 23, 2018 | Cell Care Therapeutics Raises $4.3M to Develop Treatment for Eye Diseases |
Reviews 0
FAQ about Cell Care Therapeutics
When was Cell Care Therapeutics founded?
Cell Care Therapeutics was founded in 2014.
How much funding has Cell Care Therapeutics raised?
Cell Care Therapeutics has raised $4.3M in total across 1 funding round.
What has the press written about Cell Care Therapeutics?
Parsers VC has collected 2 articles mentioning Cell Care Therapeutics, among them “Cell Care Therapeutics Raises $4.3M to Develop Treatment for Eye Diseases” (Oct 23, 2018).
Is Cell Care Therapeutics still active?
Yes, Cell Care Therapeutics is active; its latest activity on Parsers VC dates from Oct 23, 2018.